GO:0005643 nuclear pore: Components, Assembly and Research

The nuclear pore complex (NPC) is a massive proteinaceous structure that spans the nuclear envelope of eukaryotic cells, forming a discrete opening where the inner and outer nuclear membranes are joined. This complex serves as the sole gateway for the exchange of macromolecules between the nucleus and the cytoplasm, controlling the transport of proteins, RNAs, and ribonucleoprotein particles. The NPC is composed of multiple copies of approximately 30 different proteins called nucleoporins, which are organized into distinct subcomplexes, including the cytoplasmic filaments, the inner ring, the outer ring, the nuclear basket, and the central channel. Beyond its transport function, the NPC plays critical roles in chromatin organization, gene expression regulation, and cell cycle progression. Dysfunction of the nuclear pore complex has been increasingly implicated in a wide range of human pathologies, including neurodegenerative diseases, cancers, and developmental disorders [2,4,5]. For instance, mutations in nucleoporins or alterations in NPC composition can lead to defective nucleocytoplasmic transport, which is a hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Furthermore, the NPC is a target of viral pathogens and is involved in the regulation of zygotic genome activation during early development. Understanding the structure, assembly, and regulation of the NPC is therefore essential for uncovering the molecular basis of these diseases and for developing novel therapeutic strategies. Researchers studying nuclear pore biology require robust experimental models to investigate the function of individual nucleoporins and their roles in disease. CRISPR-Cas9 gene editing technology offers powerful tools to generate knockout, point mutation, knock-in, and overexpression cell models, enabling precise interrogation of NPC components [6,8]. This article provides a comprehensive overview of the nuclear pore complex, covering its definition, structure, assembly, key genes, regulation, disease associations, and the research methods used to study it.

The nuclear pore (GO:0005643) is a protein complex that forms a discrete opening in the nuclear envelope of a eukaryotic cell, where the inner and outer nuclear membranes are joined. It is also known as the nuclear pore complex (NPC), nucleopore, or nuclear pore membrane protein. This structure serves as the primary channel for the bidirectional transport of molecules between the nucleus and the cytoplasm, and it is composed of multiple copies of nucleoporins arranged in a highly organized architecture.

The nuclear pore complex is essential for maintaining the spatial and functional organization of eukaryotic cells by regulating the flow of genetic information and other macromolecules between the nucleus and cytoplasm. Its dysfunction is directly linked to a spectrum of human diseases, making it a critical area of research for understanding disease mechanisms and identifying therapeutic targets [2,4,5].

The following table lists key genes encoding nucleoporins and associated proteins that are critical for nuclear pore complex structure, function, and regulation, along with their research relevance.

The nuclear pore complex is regulated at multiple levels, including transcriptional control of nucleoporin genes, post-translational modifications of nucleoporins, and assembly/disassembly dynamics during the cell cycle. Phosphorylation by CDK1 and other mitotic kinases controls NPC disassembly at mitosis and reassembly in telophase. Additionally, the NPC is subject to quality control mechanisms that monitor its integrity, and damaged NPCs can be repaired or degraded via autophagy-related pathways. The mTOR signaling pathway has been implicated in regulating NPC function and composition, particularly in response to nutrient availability. Furthermore, the integrated stress response (ISR) can influence nucleoporin expression and NPC function under stress conditions.

Nuclear pore complex dysfunction and defective nucleocytoplasmic transport are increasingly recognized as key pathological mechanisms in neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Alzheimer's disease, and Huntington's disease [2,5]. In ALS and FTD, mutations in C9orf72 and other genes lead to impaired nucleocytoplasmic transport, mislocalization of nuclear transport receptors, and accumulation of nuclear pore damage. Post-mortem studies have revealed altered NPC composition and distribution in affected neurons. Furthermore, age-related decline in NPC function contributes to neuronal vulnerability, as post-mitotic neurons cannot replace damaged NPCs through cell division. These findings suggest that targeting NPC dysfunction could be a therapeutic strategy for neurodegeneration [2,5].

Alterations in nucleoporins and NPC components are frequently observed in various cancers, where they contribute to tumorigenesis, metastasis, and drug resistance. For example, NUP98 is recurrently involved in chromosomal translocations in leukemia, generating fusion proteins that act as oncogenic transcription factors. Overexpression of NUP88 and other nucleoporins has been reported in several solid tumors and is associated with poor prognosis. Additionally, changes in NPC composition can alter the transport of oncoproteins and tumor suppressors, thereby promoting cancer progression. Targeting nucleoporins or nuclear transport pathways is being explored as a potential anticancer strategy.

Mutations in genes encoding nucleoporins cause a range of developmental disorders, often affecting multiple organ systems [4,6]. For instance, mutations in NUP93, NUP205, and NUP160 are linked to steroid-resistant nephrotic syndrome, a kidney disorder. Mutations in NUP155 are associated with atrial fibrillation and developmental defects. Additionally, NUP107 and NUP133 mutations cause microcephaly and growth retardation. These disorders highlight the essential role of the NPC in tissue homeostasis and organ development.

Advanced imaging techniques are essential for studying the structure and dynamics of the NPC. Fluorescence microscopy, including super-resolution and live-cell imaging, allows visualization of nucleoporins tagged with fluorescent proteins in intact cells. Cryo-electron tomography (cryo-ET) combined with subtomogram averaging provides near-atomic resolution structures of the NPC in situ. Correlative light and electron microscopy (CLEM) bridges dynamic and structural information. These methods have revealed the precise arrangement of nucleoporins and their conformational changes during transport.

Mass spectrometry-based proteomics is widely used to identify NPC components and their interaction partners. Affinity purification coupled to mass spectrometry (AP-MS) of tagged nucleoporins can reveal stable and transient interactions. Proximity labeling techniques such as BioID and APEX enable mapping of the NPC interactome in living cells. Quantitative proteomics can also assess changes in nucleoporin abundance and post-translational modifications under different conditions.

Transport assays are used to measure the efficiency and specificity of nucleocytoplasmic transport. Fluorescently labeled cargoes with NLS or NES sequences are microinjected or expressed in cells, and their localization is monitored by microscopy. Permeabilized cell systems reconstituted with recombinant transport factors allow dissection of the transport machinery. Additionally, reporter systems such as the GFP-based nuclear export assay are used to screen for defects in transport.

CRISPR-Cas9 genome editing enables the generation of knockout, point mutation, knock-in, and overexpression models to study nucleoporin function [6,8]. Large-scale CRISPR screens can identify genes that modulate NPC function or resistance to transport inhibitors. These approaches are complemented by RNA interference (RNAi) and CRISPR interference (CRISPRi) for knockdown studies.

Researchers studying nuclear pore-related genes often need to determine whether a candidate gene is causally involved in NPC function or disease. This requires precise genetic manipulation, which can be achieved through CRISPR-based knockout, point mutation, knock-in, and overexpression models. EDITGENE provides comprehensive services to generate such models, enabling rigorous investigation of nuclear pore biology.

The nuclear pore complex is a fundamental cellular machine that governs nucleocytoplasmic transport and plays critical roles in development, homeostasis, and disease. Its dysfunction is implicated in a broad spectrum of human pathologies, from neurodegeneration to cancer. Advances in CRISPR gene editing and imaging technologies continue to unravel the complexities of NPC biology, offering new avenues for therapeutic intervention. EDITGENE's comprehensive services empower researchers to generate precise genetic models and accelerate discoveries in nuclear pore research.